2022-09-14 • Psychedelic Chronicle

Revitalist Partners with Wake Network To Offer Psychedelics for Veterans Upon 300% Month over Month Growth

Revitalist Lifestyle and Wellness LTD. (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) recently announced a new joint venture partnership with Wake Network, Inc. to establish the world’s first international center of excellence with a special focus on Veteran’s ethical need for access to psychedelics offering ketamine infusions in the United States along with international psilocybin clinical retreats. The news of the recent relationship with Wake Network comes just days after Revitalist announced achieving 300% month-over-month growth in serving veterans with psychedelics in the United States through coverage with the VA (United States Department of Veterans Affairs). About Wake Network Wake Network, The post Revitalist Partners with Wake Network To Offer Psychedelics for Veterans Upon 300% Month over Month Growth appeared first on Psychedelic Chronicle.

External link. We are not responsible for the content.

Read more ↗

More From Psychedelic Chronicle

2023-02-16 • Psychedelic Chronicle

Choose Ketamine Complete Capital Raise to Expand Technology Platform

In a major milestone for mental health care, Austin-based Choose Your Horizon Inc., also known as Choose Ketamine, ha...

2022-10-14 • Psychedelic Chronicle

Biomind Labs Secure FDA Pre-IND Meeting for Feedback on NCE Triptax

The well-known psychedelic biotech company Biomind Labs Inc. (NEO: BMND) (OTC: BMNDF) (FSE: 3XI) announced that it ha...

2022-10-11 • Psychedelic Chronicle

Silo Pharma Initiate Toxicity Study of Ketamine Formulation for Fibromyalgia Treatment

Silo Pharma (Nasdaq: SILO), a developmental-stage psychedelic biopharmaceutical firm, announced today that it has beg...

Latest News

2026-02-28 • Chemical Collective

Comment perfectionner la préparation de son trip ?

La préparation d’un voyage est un processus à la fois intérieur et extérieur – qui consiste à aligner l’intention, l’...

2026-02-27 • Lucid News

Authors of Largest Microdosing Study Suggest Benefits Limited To Dosing Day

Recent research surveying 1,435 microdosers suggests that microdosing’s duration of effect might be more like that of...

Microdosing Research
2026-02-27 • The Microdose (Berkeley)

The FDA is changing the drug approval process; In a Senate hearing, Surgeon General nominee Casey Means was asked about psychedelics use

Plus: RAND survey shows that nearly a quarter of U.S. adults support legal use of psilocybin mushrooms; Reunion Neuro...

2026-02-27 • Psychedelic Alpha

Psilocybin for OCD: Terence Ching on Lessons from Yale’s Randomised Trials

In this conversation with Psychedelic Alpha’s Josh Hardman, Dr. Terence Ching discusses his journey into the field an...

2026-02-27 • Tripsitter (Substack)

Can Psychedelics Break the Consumption Cycle?

Consumer culture doesn’t just shape what we buy — it shapes what we want. Here’s why that’s harder to escape than you...

2026-02-27 • The Psychedelic Blog (Substack)

Psychedelics Can Just Be for Fun

Welcome to the Psychedelic Blog. I write about the impact of Psychedelics on Grieving, Relationships, Culture & Death.